JP2016511747A5 - - Google Patents

Download PDF

Info

Publication number
JP2016511747A5
JP2016511747A5 JP2015551772A JP2015551772A JP2016511747A5 JP 2016511747 A5 JP2016511747 A5 JP 2016511747A5 JP 2015551772 A JP2015551772 A JP 2015551772A JP 2015551772 A JP2015551772 A JP 2015551772A JP 2016511747 A5 JP2016511747 A5 JP 2016511747A5
Authority
JP
Japan
Prior art keywords
composition
peptide
connective tissue
polymer
active agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015551772A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016511747A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/010162 external-priority patent/WO2014107566A1/en
Publication of JP2016511747A publication Critical patent/JP2016511747A/ja
Publication of JP2016511747A5 publication Critical patent/JP2016511747A5/ja
Pending legal-status Critical Current

Links

JP2015551772A 2013-01-04 2014-01-03 ナノ粒子表面結合に基づく薬物の組織への送達 Pending JP2016511747A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361748809P 2013-01-04 2013-01-04
US61/748,809 2013-01-04
US201361870288P 2013-08-27 2013-08-27
US61/870,288 2013-08-27
PCT/US2014/010162 WO2014107566A1 (en) 2013-01-04 2014-01-03 Surface binding of nanoparticle based drug delivery to tissue

Publications (2)

Publication Number Publication Date
JP2016511747A JP2016511747A (ja) 2016-04-21
JP2016511747A5 true JP2016511747A5 (enExample) 2017-06-29

Family

ID=51061134

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015551772A Pending JP2016511747A (ja) 2013-01-04 2014-01-03 ナノ粒子表面結合に基づく薬物の組織への送達

Country Status (4)

Country Link
US (2) US9289506B2 (enExample)
EP (1) EP2941243A4 (enExample)
JP (1) JP2016511747A (enExample)
WO (1) WO2014107566A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012040623A2 (en) 2010-09-24 2012-03-29 The Brigham And Women's Hospital, Inc. Nanostructured gels capable of controlled release of encapsulated agents
GB201412610D0 (en) * 2014-07-16 2014-08-27 Univ Cardiff Cartilage agent delivery
JP6851987B2 (ja) * 2015-12-25 2021-03-31 コニカミノルタ株式会社 ゼラチン粒子、ゼラチン粒子の製造方法、ゼラチン粒子内包細胞、およびゼラチン粒子内包細胞の製造方法
EP4166161B1 (en) 2016-04-14 2026-03-04 Fred Hutchinson Cancer Center Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
US10583199B2 (en) * 2016-04-26 2020-03-10 Northwestern University Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs
EP3452094B1 (en) * 2016-05-06 2021-11-17 The Brigham and Women's Hospital, Inc. Binary self assembled gels for controlled delivery of encapsulated agents to cartilage
WO2018129270A1 (en) * 2017-01-05 2018-07-12 Fred Hutchinson Cancer Research Center Systems and methods to improve vaccine efficacy
WO2019143948A1 (en) 2018-01-18 2019-07-25 Fred Hutchinson Cancer Research Center Altering inflammatory states of immune cells in vivo by modulating cellular activation states
CN108531616B (zh) * 2018-04-28 2021-08-10 中国农业科学院兰州畜牧与兽药研究所 一种牦牛体格相关的基因分子标记、检测方法和试剂盒
CN113825495A (zh) 2018-10-11 2021-12-21 阿利维奥治疗学股份有限公司 用于智能释放的不可注射水凝胶调配物
US12653899B2 (en) * 2019-07-26 2026-06-16 Massachusetts Institute Of Technology Multi-targeted, tunable, sustained delivery of payloads to charged avascular tissues
US20210154307A1 (en) * 2019-11-07 2021-05-27 Northeastern University Cationic nanostructures for intra-cartilage delivery of therapeutics and contrast agents

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2065346C (en) * 1989-09-05 2005-03-29 Craig A. Smith Tumor necrosis factor-.alpha. and-.beta. receptors
US8795242B2 (en) 1994-05-13 2014-08-05 Kensey Nash Corporation Resorbable polymeric device for localized drug delivery
US5723125A (en) 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
US20060084794A1 (en) * 2001-04-12 2006-04-20 Human Genome Sciences, Inc. Albumin fusion proteins
ITRM20020128A1 (it) 2002-03-08 2003-09-08 Sigma Tau Ind Farmaceuti Dimeri di avidina efficaci nell'incrementare la concentrazione di biotina radioattiva nella immunoterapia con "pretargeting".
MXPA05002514A (es) * 2002-09-06 2005-05-27 Amgen Inc Anticuerpo monoclonal anti-il-1r1 humano terapeutico.
GB0313569D0 (en) * 2003-06-12 2003-07-16 Plasso Technology Ltd Method
JP4833862B2 (ja) * 2004-01-28 2011-12-07 サイトイミューン サイエンシズ インコーポレイテッド 官能化コロイド金属組成物および方法
WO2005107818A2 (en) 2004-04-30 2005-11-17 University Of Florida Nanoparticles and their use for multifunctional bioimaging
US20090324678A1 (en) 2004-07-16 2009-12-31 Spinal Restoration, Inc. Methods and kits for treating joints and soft tissues
JP2006247155A (ja) 2005-03-11 2006-09-21 Aruze Corp タイピングゲーム装置及びデータベースシステム
MY149159A (en) 2005-11-15 2013-07-31 Hoffmann La Roche Method for treating joint damage
WO2008005509A2 (en) 2006-07-06 2008-01-10 Massachusetts Institute Of Technology Methods and compositions for altering biological surfaces
US7592009B2 (en) 2006-10-10 2009-09-22 Ecole Polytechnique Federale De Lausanne (Epfl) Polypeptide ligands for targeting cartilage and methods of use thereof
WO2008144753A2 (en) * 2007-05-21 2008-11-27 Alder Biopharmaceuticals, Inc. Antibodies to tnf alpha and use thereof
MX2010001302A (es) 2007-08-02 2010-03-01 Sigma Tau Ind Farmaceuti Avidina oxidada con tiempo de residencia elevado en tejidos tratados.
WO2009073193A2 (en) 2007-12-03 2009-06-11 The Johns Hopkins University Methods of synthesis and use of chemospheres
JP2009292787A (ja) * 2008-06-06 2009-12-17 Ab Size:Kk 軟骨再生促進剤
WO2010042555A2 (en) 2008-10-06 2010-04-15 The Brigham And Women's Hospital, Inc. Particles with multiple functionalized surface domains
US9198873B2 (en) * 2010-07-19 2015-12-01 National Cheng Kung University Functionalized nanoparticle, method for preparing the same and application thereof
PH12014500193A1 (en) 2011-08-02 2014-03-24 Alfasigma Spa Pharmaceutical composition of oxidised avidin suitable for inhalation

Similar Documents

Publication Publication Date Title
JP2019504895A5 (enExample)
JP2016509011A5 (enExample)
JP2014533698A5 (enExample)
JP2018520997A5 (enExample)
RU2014128590A (ru) Применение полимерных эксципиентов для лиофилизации или заморозки частиц
JP2016531913A5 (enExample)
JP2017537985A5 (enExample)
Dua et al. Application of chitosan and its derivatives in nanocarrier based pulmonary drug delivery systems
JP2016222689A5 (ja) 合成ペプチド及び乾燥粉末薬剤輸送システム
JP2017538672A5 (enExample)
JP2015520197A5 (enExample)
JP2015500342A5 (enExample)
JP2018509388A5 (enExample)
JP2016512248A5 (enExample)
JP2015529685A5 (enExample)
JP2016506416A5 (enExample)
JP2016521712A5 (enExample)
JP2016522261A5 (enExample)
RU2015149387A (ru) Способы применения интерлейкина-10 для лечения заболеваний и расстройств
JP2015520161A5 (enExample)
JP2019513752A5 (enExample)
JP2018524306A5 (enExample)
JP2021531282A5 (enExample)
JP2011528333A5 (enExample)
JP2014051497A5 (enExample)